South America Bioinformatics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Knowledge Management Tools, Bioinformatics Platforms, and Bio Informative Services), Application (Genomics, Chemo Informatics and Drug Design, Prote
Description
South America Bioinformatics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Knowledge Management Tools, Bioinformatics Platforms, and Bio Informative Services), Application (Genomics, Chemo Informatics and Drug Design, Proteomics, Transcriptomics, Metabolomics, and Others), and Sector (Medical Biotechnology, Academics, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Others)
The SAM bioinformatics market is expected to grow from US$ 859.12 million in 2022 to US$ 1,982.28 million by 2028; it is estimated to grow at a CAGR of 15.0% from 2022 to 2028.
Rising Demand for Personalized Medicine
Personalized medicine is an emerging practice of medicine in which the genetic profile of an individual is used to lead decisions regarding prevention, diagnosis, and treatment of disease. The genetic profile of a patient assists doctors in precisely calculating a patient's susceptibility to specific diseases and allows them to prescribe the patient a proper medication with reduced side effects. In personalized medicine, bioinformatics can be used to explore any possible mutations or gene variants affecting a patient's response to a particular drug/treatment by analyzing the patient's genome sequencing or microarray gene expression. The patient-specific medication is developed through bioinformatics tools. Bioinformatics devices may furnish better conclusions at the genomic level with prior identification of infection and better focus on treatment through improved personalized medicine. Therefore, the rising demand for personalized medicine, especially for rare diseases and cancer, is expected to provide growth opportunities for the bioinformatics market.
Market Overview
The bioinformatics market in SAM is broadly segmented into Brazil, Argentina, and Rest of SAM. Brazil dominated the market in 2022. Brazil is gaining traction in the adoption of genomic research. Initially, Brazil invested US$ 11 million to begin a genomics program through various projects. Currently, it is receiving funding from numerous organizations worldwide. This initiative fostered a strong genomics influence on the healthcare sector in the country. Also, the developments in genomics, artificial intelligence, and remote sensing have enormous potential to enhance human, animal, and environmental health and enable this progress. In Brazil, the biotechnology market has experienced several activities in terms of industrial-scale activities and healthcare. Brazil is known for its research and investment in industrial biotechnology, predominantly regarding cellulosic sugars and agribusiness. The Brazilian stakeholders, policymakers, and public investors have promoted the advancement of industrial biotechnology in Brazil. The trade groups in Brazil aim to enhance the current patent laws to support biotechnology advancements, R&D, laboratory infrastructures, and knowledge transfer by increasing training capabilities.
SAM Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
SAM Bioinformatics Market Segmentation
The SAM bioinformatics market is segmented based on product, application, sector, and country.
Based on product, the SAM bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bio informative services. The bioinformatics platforms segment held the largest market share in 2022. Based on application, the SAM bioinformatics market is segmented into genomics, chemo informatics and drug design, proteomics, transcriptomics, metabolomics, and others. The genomics segment held the largest market share in 2022. Based on sector, the SAM bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held the largest market share in 2022. Based on country, the SAM bioinformatics market has been categorized into Brazil, Argentina, and Rest of SAM. Further, Brazil dominated the market in 2022. Agilent Technologies, Inc.; Bruker Corporation; Dassault Systèmes; Eurofins Scientific; Illumina, Inc.; PerkinElmer Inc.; QIAGEN; and Thermo Fisher Scientific Inc. are the leading companies operating in the SAM bioinformatics market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM bioinformatics market.
Highlights key business priorities to assist companies to realign their business s strategies
The key findings and recommendations highlight crucial progressive industry trends in the SAM bioinformatics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the bioinformatics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
The SAM bioinformatics market is expected to grow from US$ 859.12 million in 2022 to US$ 1,982.28 million by 2028; it is estimated to grow at a CAGR of 15.0% from 2022 to 2028.
Rising Demand for Personalized Medicine
Personalized medicine is an emerging practice of medicine in which the genetic profile of an individual is used to lead decisions regarding prevention, diagnosis, and treatment of disease. The genetic profile of a patient assists doctors in precisely calculating a patient's susceptibility to specific diseases and allows them to prescribe the patient a proper medication with reduced side effects. In personalized medicine, bioinformatics can be used to explore any possible mutations or gene variants affecting a patient's response to a particular drug/treatment by analyzing the patient's genome sequencing or microarray gene expression. The patient-specific medication is developed through bioinformatics tools. Bioinformatics devices may furnish better conclusions at the genomic level with prior identification of infection and better focus on treatment through improved personalized medicine. Therefore, the rising demand for personalized medicine, especially for rare diseases and cancer, is expected to provide growth opportunities for the bioinformatics market.
Market Overview
The bioinformatics market in SAM is broadly segmented into Brazil, Argentina, and Rest of SAM. Brazil dominated the market in 2022. Brazil is gaining traction in the adoption of genomic research. Initially, Brazil invested US$ 11 million to begin a genomics program through various projects. Currently, it is receiving funding from numerous organizations worldwide. This initiative fostered a strong genomics influence on the healthcare sector in the country. Also, the developments in genomics, artificial intelligence, and remote sensing have enormous potential to enhance human, animal, and environmental health and enable this progress. In Brazil, the biotechnology market has experienced several activities in terms of industrial-scale activities and healthcare. Brazil is known for its research and investment in industrial biotechnology, predominantly regarding cellulosic sugars and agribusiness. The Brazilian stakeholders, policymakers, and public investors have promoted the advancement of industrial biotechnology in Brazil. The trade groups in Brazil aim to enhance the current patent laws to support biotechnology advancements, R&D, laboratory infrastructures, and knowledge transfer by increasing training capabilities.
SAM Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
SAM Bioinformatics Market Segmentation
The SAM bioinformatics market is segmented based on product, application, sector, and country.
Based on product, the SAM bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bio informative services. The bioinformatics platforms segment held the largest market share in 2022. Based on application, the SAM bioinformatics market is segmented into genomics, chemo informatics and drug design, proteomics, transcriptomics, metabolomics, and others. The genomics segment held the largest market share in 2022. Based on sector, the SAM bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held the largest market share in 2022. Based on country, the SAM bioinformatics market has been categorized into Brazil, Argentina, and Rest of SAM. Further, Brazil dominated the market in 2022. Agilent Technologies, Inc.; Bruker Corporation; Dassault Systèmes; Eurofins Scientific; Illumina, Inc.; PerkinElmer Inc.; QIAGEN; and Thermo Fisher Scientific Inc. are the leading companies operating in the SAM bioinformatics market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM bioinformatics market.
Highlights key business priorities to assist companies to realign their business s strategies
The key findings and recommendations highlight crucial progressive industry trends in the SAM bioinformatics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the bioinformatics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table of Contents
136 Pages
- 1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
- 1.2.1 SAM Bioinformatics Market – By Product
- 1.2.2 SAM Bioinformatics Market – By Application
- 1.2.3 SAM Bioinformatics Market – By Sector
- 1.2.4 SAM Bioinformatics Market – By Country
- 2. Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. SAM Bioinformatics Market – Market Landscape
- 4.1 Overview
- 4.2 SAM PEST Analysis
- 4.3 Expert Opinion
- 5. SAM Bioinformatics Market – Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Funding and Investments in Bioinformatics
- 5.1.2 Increased Number of Genomic Research Activities with Corresponding Adoption of Bioinformatics
- 5.2 Market Restraint
- 5.2.1 Lack of Interoperability and Multiplatform Capabilities
- 5.3 Market Opportunities
- 5.3.1 Rising Demand for Personalized Medicine
- 5.4 Future Trends
- 5.4.1 Integration of Artificial Intelligence (AI) and Machine Learning in Bioinformatics
- 5.5 Impact Analysis
- 6. Bioinformatics Market – SAM Analysis
- 6.1 SAM Bioinformatics Market Revenue Forecast & Analysis
- 7. SAM Bioinformatics Market Analysis – By Product
- 7.1 Overview
- 7.2 SAM Bioinformatics Market Revenue Share by Product (2022 and 2028)
- 7.3 Bioinformatics Platforms
- 7.3.1 Overview
- 7.3.2 Bioinformatics Platforms: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 7.4 Knowledge Management Tools
- 7.4.1 Overview
- 7.4.2 Knowledge Management Tools: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 7.5 Bioinformative Services
- 7.5.1 Overview
- 7.5.2 Bioinformative Services: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 8. SAM Bioinformatics Market Analysis – By Application
- 8.1 Overview
- 8.2 SAM Bioinformatics Market Revenue Share, by Application (2022 and 2028)
- 8.3 Genomics
- 8.3.1 Overview
- 8.3.2 Genomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 8.4 Proteomics
- 8.4.1 Overview
- 8.4.2 Proteomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 8.5 ChemoInformatics and Drug Design
- 8.5.1 Overview
- 8.5.2 ChemoInformatics and Drug Design: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 8.6 Transcriptomics
- 8.6.1 Overview
- 8.6.2 Transcriptomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 8.7 Metabolomics
- 8.7.1 Overview
- 8.7.2 Metabolomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 9. SAM Bioinformatics Market Analysis – By Sector
- 9.1 Overview
- 9.2 SAM Bioinformatics Market Share, by Sector, 2022 and 2028, (%)
- 9.3 Medical Biotechnology
- 9.3.1 Overview
- 9.3.2 Medical Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- 9.4 Animal Biotechnology
- 9.4.1 Overview
- 9.4.2 Animal Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- 9.5 Agricultural Biotechnology
- 9.5.1 Overview
- 9.5.2 Agricultural Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- 9.6 Academics
- 9.6.1 Overview
- 9.6.2 Academics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 9.7 Environmental Biotechnology
- 9.7.1 Overview
- 9.7.2 Environmental Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- 9.8 Forensic Biotechnology
- 9.8.1 Overview
- 9.8.2 Forensic Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- 9.9 Others
- 9.9.1 Overview
- 9.9.2 Others: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- 10. SAM Bioinformatics Market – Country Analysis
- 10.1 Overview
- 10.1.1 SAM: Bioinformatics Market, by Country, 2022 & 2028 (%)
- 10.1.1.1 Brazil: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 10.1.1.1.1 Overview
- 10.1.1.1.2 Brazil Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.3 Brazil: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 10.1.1.1.4 Brazil: Bioinformatics Market Revenue and Forecasts To 2028, By Application (US$ Million)
- 10.1.1.1.5 Brazil: Bioinformatics Market Revenue and Forecasts To 2028, By Sector (US$ Million)
- 10.1.1.2 Argentina: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 10.1.1.2.1 Overview
- 10.1.1.2.2 Argentina Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.3 Argentina: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 10.1.1.2.4 Argentina: Bioinformatics Market Revenue and Forecasts To 2028, By Application (US$ Million)
- 10.1.1.2.5 Argentina: Bioinformatics Market Revenue and Forecasts To 2028, By Sector (US$ Million)
- 10.1.1.3 Rest of the SAM: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- 10.1.1.3.1 Overview
- 10.1.1.3.2 Rest of the SAM Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.3 Rest of SAM: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 10.1.1.3.4 Rest of SAM: Bioinformatics Market Revenue and Forecasts To 2028, By Application (US$ Million)
- 10.1.1.3.5 Rest of SAM: Bioinformatics Market Revenue and Forecasts To 2028, By Sector (US$ Million)
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Organic Developments
- 11.2.1 Overview
- 11.3 Inorganic Developments
- 11.3.1 Overview
- 12. COMPANY PROFILES
- 12.1 Dassault Systèmes
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Bruker Corporation
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Agilent Technologies, Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Eurofins Scientific
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Illumina, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 PerkinElmer Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 QIAGEN
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Thermo Fisher Scientific Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
- LIST OF TABLES
- Table 1. SAM Bioinformatics Market – Revenue and Forecast to 2028 (US$ Mn)
- Table 2. Brazil: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- Table 3. Brazil: Bioinformatics Market Revenue and Forecasts to 2028, By Application (US$ Million)
- Table 4. Brazil: Bioinformatics Market Revenue and Forecasts to 2028, By Sector (US$ Million)
- Table 5. Argentina: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- Table 6. Argentina: Bioinformatics Market Revenue and Forecasts to 2028, By Application (US$ Million)
- Table 7. Argentina: Bioinformatics Market Revenue and Forecasts to 2028, By Sector (US$ Million)
- Table 8. Rest of SAM: Bioinformatics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- Table 9. Rest of SAM: Bioinformatics Market Revenue and Forecasts to 2028, By Application (US$ Million)
- Table 10. Rest of SAM: Bioinformatics Market Revenue and Forecasts to 2028, By Sector (US$ Million)
- Table 11. Organic Developments Done by Companies
- Table 12. Inorganic Developments Done by Companies
- Table 13. Glossary of Terms
- LIST OF FIGURES
- Figure 1. SAM Bioinformatics Market Segmentation
- Figure 2. SAM Bioinformatics Segmentation, by Country
- Figure 3. SAM Bioinformatics Market Overview
- Figure 4. SAM Bioinformatics Market, By Product
- Figure 5. SAM Bioinformatics Market, By Country
- Figure 6. SAM PEST Analysis
- Figure 7. SAM Bioinformatics Market Impact Analysis of Drivers and Restraints
- Figure 8. SAM Bioinformatics Market – Revenue Forecast and Analysis
- Figure 9. SAM Bioinformatics Market Revenue Share by Product (2022 and 2028)
- Figure 10. SAM Bioinformatics Platforms: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- Figure 11. SAM Knowledge Management Tools: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- Figure 12. SAM Bioinformative Services: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- Figure 13. SAM Bioinformatics Market Revenue Share, by Application (2022 and 2028)
- Figure 14. SAM Genomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- Figure 15. SAM Proteomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- Figure 16. SAM ChemoInformatics and Drug Design: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- Figure 17. SAM Transcriptomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- Figure 18. SAM Metabolomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- Figure 19. SAM Others: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- Figure 20. SAM Bioinformatics Market Share, by Sector, 2022 and 2028 (%)
- Figure 21. SAM Medical Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- Figure 22. SAM Animal Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- Figure 23. SAM Agricultural Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- Figure 24. SAM Academics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
- Figure 25. SAM Environmental Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- Figure 26. SAM Forensic Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- Figure 27. SAM Others: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
- Figure 28. SAM Bioinformatics Market Revenue Overview, by Country, 2022 (US$ Million)
- Figure 29. SAM: Bioinformatics Market, by Country, 2022 & 2028 (%)
- Figure 30. Brazil: Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 31. Argentina: Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 32. Rest of the SAM: Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
